Manulife (Manufacturers Life Insurance)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Sell
300,160
-21,321
-7% -$1.42M 0.02% 650
2026
Q1
$20.2M Buy
321,481
+17,311
+6% +$1.21M 0.02% 602
2025
Q4
$20.2M Buy
304,170
+51,430
+20% +$3.32M 0.02% 642
2025
Q3
$17M Sell
252,740
-4,163
-2% -$329K 0.01% 680
2025
Q2
$22.4M Sell
256,903
-7,313
-3% -$573K 0.02% 581
2025
Q1
$18M Sell
264,216
-9,062
-3% -$739K 0.02% 632
2024
Q4
$21.3M Sell
273,278
-1,873
-0.7% -$139K 0.02% 607
2024
Q3
$18.4M Sell
275,151
-14,673
-5% -$1.2M 0.02% 658
2024
Q2
$32.9M Buy
289,824
+1,998
+0.7% +$253K 0.03% 450
2024
Q1
$39.9M Sell
287,826
-26,747
-9% -$3.36M 0.04% 404
2023
Q4
$39M Buy
314,573
+1,363
+0.4% +$139K 0.02% 419
2023
Q3
$29.2M Sell
313,210
-10,786
-3% -$1.22M 0.02% 477
2023
Q2
$41.6M Sell
323,996
-16,293
-5% -$1.97M 0.02% 376
2023
Q1
$39.5M Sell
340,289
-16,393
-5% -$1.84M 0.02% 394
2022
Q4
$40.3M Buy
356,682
+1,026
+0.3% +$113K 0.03% 386
2022
Q3
$28.7M Buy
355,656
+8,068
+2% +$683K 0.02% 456
2022
Q2
$26M Sell
347,588
-2,200
-0.6% -$201K 0.02% 506
2022
Q1
$44.8M Buy
349,788
+56,724
+19% +$6.2M 0.03% 407
2021
Q4
$39.4M Sell
293,064
-80,144
-21% -$11.5M 0.02% 433
2021
Q3
$51M Sell
373,208
-12,656
-3% -$1.6M 0.04% 367
2021
Q2
$41.2M Sell
385,864
-4,944
-1% -$475K 0.03% 423
2021
Q1
$35.1M Buy
390,808
+2,908
+0.7% +$273K 0.03% 458
2020
Q4
$35.9M Sell
387,900
-27,984
-7% -$2.5M 0.03% 411
2020
Q3
$42.9M Buy
415,884
+10,152
+3% +$1.06M 0.04% 351
2020
Q2
$40.4M Buy
405,732
+397,080
+4,589% +$35.5M 0.04% 356
2020
Q1
$582K Sell
8,652
-300
-3% -$18.7K ﹤0.01% 1755
2019
Q4
$490K Sell
8,952
-600
-6% -$28.5K ﹤0.01% 2056
2019
Q3
$355K Sell
9,552
-72
-0.7% -$2.8K ﹤0.01% 2214
2019
Q2
$361K Sell
9,624
-480
-5% -$15.1K ﹤0.01% 2250
2019
Q1
$301K Buy
10,104
+64
+0.6% +$2.25K ﹤0.01% 2265
2018
Q4
$301K Buy
10,040
+1,500
+18% +$47.6K ﹤0.01% 2163
2018
Q3
$305K Sell
8,540
-1,084
-11% -$33.6K ﹤0.01% 2533
2018
Q2
$229K Sell
9,624
-508
-5% -$10.8K ﹤0.01% 3025
2018
Q1
$188K Sell
10,132
-1,800
-15% -$26.6K ﹤0.01% 3064
2017
Q4
$171K Sell
11,932
-2,080
-15% -$27K ﹤0.01% 3122
2017
Q3
$172K Buy
14,012
+996
+8% +$17.6K ﹤0.01% 3095
2017
Q2
$238K Buy
13,016
+1,416
+12% +$26.2K ﹤0.01% 2869
2017
Q1
$246K Sell
11,600
-88
-0.8% -$1.72K ﹤0.01% 2682
2016
Q4
$175K Buy
11,688
+2,068
+21% +$36.6K ﹤0.01% 2883
2016
Q3
$211K Buy
9,620
+464
+5% +$10.3K ﹤0.01% 2738
2016
Q2
$181K Buy
9,156
+60
+0.7% +$1.02K ﹤0.01% 2783
2016
Q1
$149K Buy
9,096
+64
+0.7% +$1.07K ﹤0.01% 2807
2015
Q4
$185K Hold
9,032
﹤0.01% 2720
2015
Q3
$194K Sell
9,032
-52
-0.6% -$1.16K ﹤0.01% 2674
2015
Q2
$182K Sell
9,084
-187,420
-95% -$3.29M ﹤0.01% 2931
2015
Q1
$3.06M Sell
196,504
-387,832
-66% -$5.86M ﹤0.01% 1263
2014
Q4
$8.04M Sell
584,336
-299,964
-34% -$3.67M 0.01% 747
2014
Q3
$8.84M Sell
884,300
-365,564
-29% -$3.74M 0.01% 690
2014
Q2
$12.4M Sell
1,249,864
-55,796
-4% -$494K 0.02% 550
2014
Q1
$13.5M Sell
1,305,660
-143,344
-10% -$1.48M 0.02% 553
2013
Q4
$12.8M Sell
1,449,004
-18,260
-1% -$145K 0.02% 559
2013
Q3
$10.4M Buy
1,467,264
+613,088
+72% +$3.88M 0.02% 620
2013
Q2
$4.79M Buy
+854,176
New +$4.09M 0.01% 895

Other funds holding DXCM

Manulife (Manufacturers Life Insurance)'s DXCM Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its DexCom (DXCM) stake by 6.6% in Q2 2026, selling an estimated $1.42M and leaving 300,160 shares worth $20.2M. The position accounts for 0.02% of the portfolio, ranked #650.

Manulife (Manufacturers Life Insurance) first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $51M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 300,160 shares of DexCom worth $20.2M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 21,321 DexCom shares in Q2 2026, an estimated $1.42M.
  • DexCom made up 0.02% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #650 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
  • Manulife (Manufacturers Life Insurance)'s DexCom position peaked at $51M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.